Frontlight ResearchEarly access
Trial site
University Cancer and Blood Center
- 2running trials
- 5closed trials
The trials here
What the 7 trials at this site are about, from their registry records.
- Conditions
- Lung cancer6 trials
- Sarcoma3 trials
- Colorectal cancer2 trials
- Bladder cancer1 trial
- Childhood cancers1 trial
- Gastric and oesophageal cancer1 trial
- Head and neck cancer1 trial
- Kidney cancer1 trial
- Liver and biliary tract cancer1 trial
- Ovarian cancer1 trial
- Pancreatic cancer1 trial
- Prostate cancer1 trial
- and 1 more
- Phase
- Phase 23 trials
- Phase 33 trials
- Phase 1/21 trial
- Status
- Completed3 trials
- Terminated2 trials
- Active, not recruiting1 trial
- Recruiting1 trial
- Lead sponsor
- Boehringer Ingelheim1 trial
- Elevation Oncology1 trial
- EMD Serono Research & Development Institute, Inc.1 trial
- NeoImmuneTech1 trial
- Revolution Medicines, Inc.1 trial
- and 2 more
Running trials
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Childhood cancers1 recruiting
- Colorectal cancer1 recruiting
- Lung cancer1 recruiting
- Sarcoma1 recruiting
- Thyroid cancer1 recruiting
Closed trials
Completed
Terminated
Terminated
Study of Seribantumab in Adult Patients With NRG1 Gene Fusion Positive Advanced Solid Tumors
Completed
A Study of Tepotinib Plus Osimertinib in Osimertinib Relapsed MET Amplified NSCLC (INSIGHT 2)
Completed
A Study of Brigatinib Compared to Alectinib in Adults With Non-Small-Cell Lung Cancer
Site data: ClinicalTrials.govUpdated 12 Nov 2026